Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curegenix

Curegenix
2009 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
4 INVESTORS
Description

Developer of novel drugs intended to treat stem cell related diseases. The company's novel drugs are made of standard cell compartment for high-end biological reagents, enabling doctors in the treatment of tumors and organ fibrosis and other diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Guangzhou International Pharmaceutical Technology Co., Ltd.
  • International Business Incubator D Building, 10th Floor
  • Guangzhou, 510663
  • China

+86 020 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Curegenix’s full profile, request a free trial.

Curegenix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Jan-2016 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2014 00.000 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Curegenix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Eight Roads Ventures Venture Capital Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
Cenova Capital Venture Capital Minority 000 0000 000000 0
Cowin Venture Venture Capital Minority 000 0000 000000 0